Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method". - Wikidata - awgldk - TriplyDB

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

http://www.wikidata.org/entity/Q35208839

about

Helicobacter pylori Antibody Titer and Gastric Cancer Screening Kyoto global consensus report on Helicobacter pylori gastritis Gastric cancer: prevention, screening and early diagnosis Chronic gastritis.Combination of Helicobacter pylori Antibody and Serum Pepsinogen as a Good Predictive Tool of Gastric Cancer Incidence: 20-Year Prospective Data From the Hisayama Study.Serum trefoil factor 3 is a promising non-invasive biomarker for gastric cancer screening: a monocentric cohort study in China.Gastric mucosal status in populations with a low prevalence of Helicobacter pylori in Indonesia.The potential value of serum pepsinogen for the diagnosis of atrophic gastritis among the health check-up populations in China: a diagnostic clinical research Virulence genes of Helicobacter pylori in the Dominican Republic.Metachronous gastric cancer after successful Helicobacter pylori eradication.Differences in the levels of gastric cancer risk factors between Nanjing and Minqing counties, China.Structure and function studies on enzymes with a catalytic carboxyl group(s): from ribonuclease T1 to carboxyl peptidases Biomarkers for Helicobacter pylori infection and gastroduodenal diseases.Prevalence of Helicobacter pylori infection and atrophic gastritis in patients with dyspeptic symptoms in Myanmar.Serum pepsinogen II is a better diagnostic marker in gastric cancer.Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.Aberrant methylation of PCDH10 and RASSF1A genes in blood samples for non-invasive diagnosis and prognostic assessment of gastric cancer Seroprevalence of Helicobacter pylori infection and gastric mucosal atrophy in Bhutan, a country with a high prevalence of gastric cancer Identification of serum miRNAs as novel non-invasive biomarkers for detection of high risk for early gastric cancer.Serum Helicobacter pylori CagA antibody titer as a useful marker for advanced inflammation in the stomach in Japan.Markers for gastric cancer premalignant lesions: where do we go?Recent development of gastric cancer prevention.Systematic review: serum autoantibodies in the early detection of gastric cancer.Implementation of gastric cancer screening - the global experience.Multicentric randomised study of Helicobacter pylori eradication and pepsinogen testing for prevention of gastric cancer mortality: the GISTAR study.Detection of gastric atrophy by circulating pepsinogens: A comparison of three assays.Cost-effectiveness of combined serum anti-Helicobacter pylori IgG antibody and serum pepsinogen concentrations for screening for gastric cancer risk in Japan.Three-dimensional combined biomarkers assay could improve diagnostic accuracy for gastric cancer.A significant increase in the pepsinogen I/II ratio is a reliable biomarker for successful Helicobacter pylori eradication.Association between Gastric Cancer Risk and Serum Helicobacter pylori Antibody Titers.Serological Evaluation of Gastric Cancer Risk Based on Pepsinogen and Helicobacter pylori Antibody: Relationship to Endoscopic Findings.Cutoff Pepsinogen Level for Predicting Unintendedly Eradicated Cases of Helicobacter pylori Infection in Subjects with Seemingly Normal Pepsinogen Levels.A Serological Biopsy Using Five Stomach-Specific Circulating Biomarkers for Gastric Cancer Risk Assessment: A Multi-Phase Study.Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.Helicobacter pylori infection and its related factors in junior high school students in Nagano Prefecture, Japan.Analysis of the cost-effectiveness of using vonoprazan-amoxicillin-clarithromycin triple therapy for first-line Helicobacter pylori eradication.Onset of Ulcerative Colitis after Helicobacter pylori Eradication Therapy: A Case Report.Oxyntic gastric atrophy in Helicobacter pylori gastritis is distinct from autoimmune gastritis.Prediction of the 10-year probability of gastric cancer occurrence in the Japanese population: the JPHC study cohort II.The new modified ABCD method for gastric neoplasm screening.

P2860

Q26780322-DA542C95-2B74-4AD9-ABF4-636E280D6814 Q26799430-804ADE8A-CE45-4D7A-A2C7-91CC91DBBD5A Q26860418-4345E164-185C-45D7-8A7C-A106ACA119F3 Q30374031-375B0197-34EB-4904-89D4-D651F292F641 Q31105829-F3545699-FACA-42E3-813E-257461BF8F19 Q33574985-B0382CEF-B79A-43A9-A19B-14A0DD26E9F9 Q33626437-D3EA7173-907F-44A9-BDF5-61102936413D Q33921574-C6FE3CE9-F03A-41D2-AA15-3B57B2521C09 Q34073186-A0CDB66F-FD24-456E-A4BB-69B01CC3E321 Q34137273-392DAEB2-05D4-4962-A7A9-143BE871784A Q34293046-C766ACD3-D5CD-442C-870B-DB3880D9E26E Q34350417-CAE0D796-AAD3-4225-B9B2-FF52F341F3C3 Q34624649-810DB268-4C3A-48BA-B2F5-A464552DA6DF Q34974132-C1B392D6-D3CC-4FE3-BDDA-4E1EFE815EBE Q36529253-173FA9D7-FF5E-4E71-A2E9-A8D1E9B80211 Q36747546-3FAFE2F6-6C77-432B-A8BE-E5A5F3081BCE Q37001109-9AEDCDB0-61CA-43F2-8092-277F0A1C94B5 Q37236092-25A082E3-7973-4C43-8223-289C1B3607BD Q37279280-2195425E-4364-4682-85D3-E93A9A80E443 Q37407976-39D014B5-5773-445B-96E0-9752B53B63BE Q38020730-01287BE8-3AD1-43F3-8A91-5A2C8AA0A361 Q38047220-D07105E1-0C62-4E00-B449-2F442E5826CC Q38194925-90ED407B-5C1B-48A1-B966-2ACF8F6CE753 Q38273499-12BC26AA-1760-4AA0-B319-79581587FCEA Q38628238-8DC133B2-25CE-498B-8C03-E9B6BCEA4673 Q38677357-8476ED13-766D-450E-950E-8BB06BA3AF73 Q38760536-9C9B3E59-8060-41D5-B8FD-FFDF783D83E3 Q40039986-7567220A-98F5-480C-A5C0-389B23717101 Q40074608-2F16CF8C-B6BE-4ACE-9FB4-38BB87940604 Q40142376-F7B30FC3-130A-409D-AECE-A06E886B42B4 Q40189054-4BC1DF54-DE5B-4215-AAF5-9856972DBEFB Q40273393-B5B52ED6-7B92-484E-9F4F-566489C9DD50 Q40282956-5ED3FA0D-16A7-46DE-83C2-944EDD3E8890 Q40394526-10CEC2F9-EF17-433A-A72C-5E22351FA105 Q40416099-921B997D-6B8C-4935-827B-225AFD568466 Q40468767-AC3B44F6-2146-41FE-A5D1-CA00C8B60CEE Q40729248-5A3F4CCB-B475-4E67-80C1-920BF0F57CDC Q40846207-5BBABB5C-C715-496C-9BB1-41A46FE18994 Q41085736-9347A836-6526-4EFD-96BF-A0AE7311AC07 Q41462323-FD374576-1929-41C1-91B2-10C421D9D333

P2860

Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels - "ABC method".

http://www.wikidata.org/entity/Q35208839

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@ast

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@en

type

label

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@ast

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@en

prefLabel

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@ast

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@en

P1433

Q35208839-21DE9845-1AF1-4801-8CA8-C0CFF1608DA8

P1476

Q35208839-28CB86EF-6561-4010-8708-82F34C8E199D

P2093

Q35208839-766E4907-F44B-4E2C-AE39-2D12BCFE00A9

P2860

Q35208839-00FF1A8B-A891-45F0-9C23-A48B02A2BB58

Q35208839-096C8842-96A3-41F4-97D8-E25278D419E5

Q35208839-099D65BA-6723-4D79-B99A-8DDCB2E27754

Q35208839-0C4CD921-81C1-4001-93B5-96ED14D4BA77

Q35208839-0D946151-5984-40F8-8612-F9EC0B55FE40

Q35208839-15562821-5510-4D8B-8CA4-9E19E1614B1B

Q35208839-17E3645D-E2CE-4F50-8B51-82575355056A

Q35208839-1BBFF0F1-D639-4915-ABE7-5E13DF43746C

Q35208839-2098B156-33CE-4F29-A58D-E3A7FBD998D7

Q35208839-2A2E24F8-A5D2-4D3D-A7BF-D45A989B26AE

P304

Q35208839-828F3C12-5F3B-45A5-911A-69B57CC1D378

P31

Q35208839-17BF4126-608C-46D4-9DC2-0419E9CFC70D

Q35208839-CED1DC0C-D4B2-4E99-A9C7-FC117F1FE6B4

P356

Q35208839-DFBABF21-78B1-4361-9790-6C43CFD1DB09

P433

Q35208839-1518E8B5-15D4-44D6-9EAF-96FDFC6E5B50

P478

Q35208839-2F1E3EDB-E209-4A2A-8E5F-1E3F8FCA038F

P577

Q35208839-4F80EFDA-1ADC-4847-A883-C763E09D6107

P5875

Q35208839-A2D21156-DC2F-487E-AEEA-C665FD009FC0

P698

Q35208839-E6F8F43D-18D7-4B2C-A837-6EFEDDD9DA23

P921

Q35208839-333D512F-790E-4188-9942-382694B03C86

Q35208839-86408B1F-10A5-4C84-9708-945FF1074B90

Q35208839-B9F0B8FF-9E8B-4881-877E-C7C0B10410C2

Q35208839-CBF091A2-6B9D-4299-A81D-FFEB7A30B298

Q35208839-CE004D77-D8FA-4274-B853-BBEC2CF25C31

Q35208839-DA6A3EC4-9706-4C7A-9331-DF3B016F3971

Q35208839-E1934D28-3D61-4073-AB0B-2B633FA6F434

Q35208839-E5E1CDE1-7553-4F9A-A68C-FE3DBA522A03

Q35208839-FE81D456-4BAE-46E4-A393-3A53B2D9D5F3

P932

Q35208839-F9BCEB25-EDD6-441B-B094-A2B785595C6A

P356

P1433

Proceedings of the Japan Academy, Series B

P1476

Gastric cancer screening by co ...... sinogen levels - "ABC method".

@en

P2093

Kazumasa Miki

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics, 2002

Oncogenic mechanisms of the Helicobacter pylori CagA protein

Helicobacter pylori infection and the development of gastric cancer

Helicobacter pylori infection and the risk of gastric carcinoma

Eradication of gastric cancer and more efficient gastric cancer surveillance in Japan: two peas in a pod.

Helicobacter pylori infection is the primary cause of gastric cancer.

Pathology of gastric intestinal metaplasia: clinical implications.

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial.

Strategy for eliminating gastric cancer in Japan.

Relationship of Helicobacter pylori to serum pepsinogens in an asymptomatic Japanese population.

P304

405-414

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2183/PJAB.87.405

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51517559

http://www.w3.org/2001/XMLSchema#string

P698

21785258

http://www.w3.org/2001/XMLSchema#string

P921

stomach neoplasm

Helicobacter pylori

protein precursor

P932

3171284

http://www.w3.org/2001/XMLSchema#string